Dottikon ES Holding
Dottikon ES Holding AG is a Swiss multinational chemical and pharmaceutical manufacturing enterprise specializing in the research, development, and production of high-performance fine chemicals, chemical intermediates, pharmaceutical active ingredients (APIs), and safety-critical energetic materials for global pharmaceutical, agrochemical, and specialty chemical industries. The company operates specialized hazardous chemical synthesis plants and safety-engineered production facilities in Dottikon, Switzerland, supplying custom synthesis and contract manufacturing services to major global life science enterprises. Its core business operations encompass specialty chemical synthesis, pharmaceutical API manufacturing, hazardous reaction engineering, and international wholesale distribution. Revenue is derived directly from the global wholesale sale of fine chemicals and pharmaceutical ingredients to industrial clients. Dottikon ES Holding holds a dominant European market position in safety-critical chemical synthesis and pharmaceutical intermediate manufacturing. The company is headquartered in Dottikon, Switzerland, and its registered shares trade on the SIX Swiss Exchange.
4 of the funds FundTelligence covers report a position in Dottikon ES Holding.
- Legal name
- Dottikon ES Holding AG
- Sector
- Health Care
- Country
- Switzerland
- Funds holding it
- 4
Funds holding Dottikon ES Holding
- BlackRock iShares Healthcare Innovation UCITS ETF — BlackRock · 0.11 % (full portfolio disclosed, October 2026)
- Handelsbanken Global SMB Index Criteria — Handelsbanken · 0.02 % (full portfolio disclosed, October 2026)
- DNB Global Enhanced Small Cap — DNB · 0.01 % (full portfolio disclosed, September 2026)
- KLP AksjeGlobal Small Cap Indeks — KLP · 0.01 % (partially disclosed portfolio, June 2026)